Lifeforce is your personalized longevity partner, providing you with a comprehensive blood panel, functional medicine support and coaching, advanced nutraceuticals, and hormone replacement therapy.
About the company
Lifeforce is a pioneering platform in the realm of precision medicine, co-founded by Tony Robbins, Dr. Peter Diamandis, and Dr. Robert Hariri. Positioned as a comprehensive solution for individualized healthcare, Lifeforce empowers people to take control of their health, happiness, and vitality. By offering a range of resources, tools, and treatments, the platform enables users to make informed decisions at the right time, effectively serving as a one-stop-shop for all health-related needs. Lifeforce aims to democratize access to cutting-edge medical information and breakthroughs, making it easier for individuals to achieve peak performance and lead a more vital life.
Why We Invested
The existing healthcare model often limits personalized care, offering standardized treatments that fail to meet individual health needs effectively. Lifeforce disrupts this one-size-fits-all approach by leveraging precision medicine to provide customized healthcare solutions. Co-founded by renowned leaders like Tony Robbins, Dr. Peter Diamandis, and Dr. Robert Hariri, Lifeforce embodies a fusion of expert insights and innovative health management tools.
Current healthcare systems frequently overlook the unique genetic, environmental, and lifestyle factors that affect an individual’s health. Lifeforce addresses this gap with a platform that not only offers personalized resources and treatments but also ensures timely and informed healthcare decisions. This empowers individuals to achieve optimal health, happiness, and vitality.
By investing in Lifeforce, we support a shift towards a healthcare model where access to cutting-edge medical information and treatments is democratized, allowing people to perform at their best and lead fuller lives. Lifeforce represents a transformative step in making advanced, personalized medical care accessible to a broader audience.